Published in Am J Respir Crit Care Med on July 16, 2010
A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med (2012) 1.75
High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis (2011) 1.72
T cell homing to epithelial barriers in allergic disease. Nat Med (2012) 1.58
The role of allergy in severe asthma. Clin Exp Allergy (2012) 1.54
Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol (2011) 1.21
Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J Allergy Clin Immunol (2012) 1.17
The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J Immunol (2012) 1.13
Impact of Aspergillus fumigatus in allergic airway diseases. Clin Transl Allergy (2011) 1.03
Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat Med (2013) 1.03
Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy (2014) 1.03
OX40/OX40 ligand interactions in T-cell regulation and asthma. Chest (2012) 1.01
Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One (2013) 0.98
Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int (2013) 0.91
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy (2012) 0.89
Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol (2011) 0.87
Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS One (2013) 0.83
Update in asthma 2010. Am J Respir Crit Care Med (2011) 0.81
Asthma and allergy development: contrasting influences of yeasts and other fungal exposures. Clin Exp Allergy (2015) 0.81
The link between mold sensitivity and asthma severity in a cohort of northern Chinese patients. J Thorac Dis (2015) 0.78
Sputum Inflammatory Mediators Are Increased in Aspergillus fumigatus Culture-Positive Asthmatics. Allergy Asthma Immunol Res (2017) 0.75
CXC chemokine superfamily induced by Interferon-γ in asthma: a cross-sectional observational study. Asthma Res Pract (2016) 0.75
Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice. PLoS One (2017) 0.75
ABPA or AFAA: That Is the Question. Am J Respir Crit Care Med (2011) 0.75
Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma. J Asthma Allergy (2017) 0.75
Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India. Lung India (2017) 0.75
NADPH Oxidase-4 Overexpression Is Associated With Epithelial Ciliary Dysfunction in Neutrophilic Asthma. Chest (2016) 0.75
Association Between Sensitization to Mold and Impaired Pulmonary Function in Children With Asthma. Allergy Asthma Immunol Res (2017) 0.75
Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis. Med Mycol Case Rep (2017) 0.75
Understanding interobserver agreement: the kappa statistic. Fam Med (2005) 22.77
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med (2008) 3.39
Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest (2001) 3.19
Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ (2002) 2.81
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med (2006) 1.88
Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med (2002) 1.87
Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest (2000) 1.68
Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol (2002) 1.57
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med (2000) 1.55
Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest (2007) 1.46
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses (2003) 1.45
Allergic bronchopulmonary aspergillosis. Allergy (2005) 1.39
Optimal combination and concentration of antibiotics in media for isolation of pathogenic fungi and Nocardia asteroides. Appl Microbiol (1971) 1.26
Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol (2003) 1.22
Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy (2009) 1.18
Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J (1999) 1.13
Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest (2005) 1.12
Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med Mycol (2005) 1.00
Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol (2007) 1.00
Allergic bronchopulmonary aspergillosis: a review. J R Soc Med (1992) 0.95
Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci (2003) 0.94
Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med (1997) 0.90
A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol (1978) 0.90
Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity. Respir Care (2008) 0.84
Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev (2003) 0.81
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med (2009) 8.36
Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med (2013) 4.95
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med (2014) 4.95
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83
Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83
Asthma control during the year after bronchial thermoplasty. N Engl J Med (2007) 4.79
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58
Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74
Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol (2012) 2.68
Prevalence, pathogenesis, and causes of chronic cough. Lancet (2008) 2.60
The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med (2007) 2.44
Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax (2007) 2.37
Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest (2010) 2.29
Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol (2002) 2.28
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol (2012) 2.24
Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J (2013) 2.16
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13
Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07
Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med (2003) 1.98
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95
TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol (2002) 1.92
Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol (2008) 1.92
Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol (2005) 1.87
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med (2006) 1.86
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med (2012) 1.85
The influence of age on induced sputum differential cell counts in normal subjects. Chest (2004) 1.82
Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol (2008) 1.76
Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest (2010) 1.73
Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol (2007) 1.71
Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis (2006) 1.61
Detection of cough signals in continuous audio recordings using hidden Markov models. IEEE Trans Biomed Eng (2006) 1.53
Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med (2006) 1.53
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol (2004) 1.52
Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest (2007) 1.46
Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology (2013) 1.45
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol (2013) 1.45
C3a, mast cells, and asthma. FASEB J (2005) 1.42
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol (2011) 1.38
A comparison of the validity of different diagnostic tests in adults with asthma. Chest (2002) 1.36
Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol (2008) 1.34
An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest (2006) 1.33
Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J (2006) 1.30